Thermo Fisher Scientific Introduces Invitrogen™ SuperScript™ V Reverse Transcriptase for Faster, More Flexible RNA-to-cDNA Workflows

/

New engineered enzyme and ready-to-use master mix combine rapid, sensitive cDNA synthesis with exceptional stability and simplified setup.

 

 Overview: As RNA research grows in scale and complexity, researchers need tools that can keep pace with more challenging samples and advanced analysis. Invitrogen™ SuperScript™ V Reverse Transcriptase is a next-generation engineered enzyme designed to make the critical step of converting RNA to cDNA faster, easier and more flexible.

SuperScript V combines strong performance with room-temperature stability and simpler setup. Available as a standalone enzyme and in ready-to-use master mix formats, it supports workflows ranging from individual experiments to high-throughput and automated cDNA synthesis.

“Our goal is to empower researchers to move from sample to insights faster and with greater confidence,” said Pawan Singh, vice president and general manager, molecular biology, Thermo Fisher Scientific. “With SuperScript V, we’ve taken what researchers have trusted about SuperScript for decades and redefined what’s possible with faster, more flexible and highly stable RNA-to-cDNA synthesis.”

 
Key Customers and Applications: ·                Molecular biology and genomics researchers: Scientists performing RNA-to-cDNA workflows for gene expression, sequencing and transcriptomics.

·                Researchers working with challenging RNA: Scientists analyzing low-input, degraded, inhibitor-rich or other difficult RNA samples.
·                High-throughput laboratories: Core labs and other research teams processing larger numbers of samples manually or through automated systems.
Features/Benefits: ·                More flexible setup: Reactions can be prepared at room temperature, with assembled reactions remaining stable for up to 24 hours, giving researchers more flexibility to batch samples, manage delays and support manual, high-throughput and automated workflows.

 

·                Faster workflows: Speedy cDNA synthesis enables target detection with reaction times as short as one to 10 minutes, helping shorten an important step in RNA analysis.

·                Excellent performance: Supports sensitive, high-quality cDNA synthesis across a broad range of RNA samples, with thermostability up to 65°C.

 

·                Simplified workflows: DTT-free formulations and ready-to-use master mix options help reduce preparation and pipetting steps, while reduced cold-chain requirements provide greater flexibility in reagent handling and shipping.
Website: https://www.thermofisher.com/us/en/home/life-science/pcr/reverse-transcription/superscript-reverse-transcriptase.html

 

 

For research use only. Not for use in diagnostic procedures.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

< | >